Table 2.
Characteristics of subjects in the present study at baseline (n = 362).
| Non-CAD (n = 121) | CAD (n = 241) | P value | |
|---|---|---|---|
| Age (years) | 61.29 ± 11.47 | 62.51 ± 10.41 | 0.734 |
| Male (%) | 89 (73.55) | 172 (71.37) | 0.969 |
| Smoking (%) | 50 (41.32) | 103 (42.74) | 0.864 |
| Drinking (%) | 43 (35.54) | 97 (40.25) | 0.493 |
| DM (%) | 33 (27.27) | 95 (39.42) | 0.072 |
| HBP (%) | 77 (63.64) | 140 (58.09) | 0.430 |
| BMI (kg/m2) | 24.08 ± 1.62 | 25.02 ± 3.50 | 0.239 |
| TC (mmol/L) | 3.89 ± 1.06 | 4.05 ± 0.89 | 0.492 |
| TG (mmol/L) | 1.58 ± 1.37 | 1.67 ± 0.84 | 0.727 |
| HDL-C (mmol/L) | 1.13 ± 0.22 | 1.05 ± 0.19 | 0.114 |
| LDL-C (mmol/L) | 1.98 ± 0.61 | 2.48 ± 0.78 | 0.009 |
| FBG (mmol/L) | 5.61 ± 2.08 | 6.50 ± 3.35 | 0.256 |
| HOMA-IR | 1.50 ± 1.23 | 2.69 ± 1.01 | 0.025 |
| CRP (mg/L) | 1.41 ± 1.07 | 5.81 ± 1.23 | 0.034 |
| TNF-α (pg/mL) | 7.31 ± 2.87 | 8.26 ± 3.71 | 0.019 |
| IL-6 (pg/mL) | 3.69 ± 0.82 | 4.96 ± 1.35 | 0.039 |
| Leptin (pg/mL) | 7.42 ± 2.69 | 8.23 ± 3.05 | 0.020 |
| APN (ng/mL) | 10.67 ± 2.74 | 9.41 ± 1.49 | 0.021 |
| CTRP9 (pg/mL) | 96.14 ± 33.13 | 83.89 ± 36.18 | 0.005 |
DM: diabetes mellitus; HBP: hypertension; BMI: body mass index; TC: total cholesterol; TG: triglyceride; LDL-C: low-density lipoprotein-cholesterol; HDL-C: high-density lipoprotein-cholesterol; FBG: fasting blood glucose; HOMA-IR: homeostasis model of assessment for insulin resistance; CRP: C-reactive protein; TNF-α: tumor necrosis factor-α; IL-6: interleukin-6; APN: adiponectin; CTRP9: C1q/TNF-Related Protein-9.